
Keywords: تعویض فنوتیپ; Phenotype switching; Melanoma; Cancer-associated fibroblasts; Drug resistance; Tumor-stroma interactions; CAF; Cancer associated fibroblasts; CDSS; Cancer drug sensitivity screening; EMT; Epithelial-to-mesenchymal transition; FACS; Fluorescence-activated